AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 211 filers reported holding AMICUS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $11,498,000 | +58.6% | 845,466 | +11.7% | 0.01% | +40.0% |
| Q4 2018 | $7,251,000 | -60.3% | 756,906 | -50.0% | 0.01% | -9.1% |
| Q3 2018 | $18,284,000 | +56.9% | 1,512,372 | +102.8% | 0.01% | -26.7% |
| Q2 2018 | $11,651,000 | +7.1% | 745,925 | +3.1% | 0.02% | +7.1% |
| Q1 2018 | $10,882,000 | +13.9% | 723,548 | +9.0% | 0.01% | +16.7% |
| Q4 2017 | $9,554,000 | -3.7% | 663,936 | +0.9% | 0.01% | -7.7% |
| Q3 2017 | $9,924,000 | +276.8% | 658,078 | +151.6% | 0.01% | +225.0% |
| Q2 2017 | $2,634,000 | +45.8% | 261,545 | +3.2% | 0.00% | +33.3% |
| Q1 2017 | $1,807,000 | +51.1% | 253,499 | +5.4% | 0.00% | +50.0% |
| Q4 2016 | $1,196,000 | -20.3% | 240,563 | +18.6% | 0.00% | 0.0% |
| Q3 2016 | $1,501,000 | +35.5% | 202,858 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,108,000 | -24.3% | 202,858 | +17.1% | 0.00% | -33.3% |
| Q1 2016 | $1,464,000 | -12.0% | 173,294 | +1.0% | 0.00% | 0.0% |
| Q4 2015 | $1,664,000 | -29.3% | 171,544 | +2.0% | 0.00% | -40.0% |
| Q3 2015 | $2,353,000 | +18.4% | 168,196 | +19.7% | 0.01% | +25.0% |
| Q2 2015 | $1,988,000 | +2037.6% | 140,502 | +211.6% | 0.00% | – |
| Q1 2014 | $93,000 | -12.3% | 45,095 | 0.0% | 0.00% | – |
| Q4 2013 | $106,000 | +1.0% | 45,095 | 0.0% | 0.00% | – |
| Q3 2013 | $105,000 | +29.6% | 45,095 | +29.5% | 0.00% | – |
| Q2 2013 | $81,000 | – | 34,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |